Cathy Gwin
Senior Director, Communications
News
Media Contact
NTI, Concordia AI Launch International Working Group to Improve Biological Capability Evaluations
NTI | bio and Concordia AI, with technical input from SecureBio, have launched the AIxBio Technical Working Group on Evaluation Practice. Convened through the AIxBio Global Forum, the Working Group will bring together experts from organizations in China, the European Union, the United Kingdom, and the United States that develop or conduct biological capability evaluations of AI systems.
NTI CEO Christine Wormuth on Opportunities to Strengthen Security Through Cooperation at the Trump-Xi Summit
The Summit can produce outcomes that strengthen U.S. national security and reduce global nuclear and biological risks
NTI and CACDA Issue Joint Statement Calling for Stronger Biosecurity and Responsible AI-Biotechnology Innovation
Amid rapid advances in bioscience and as artificial intelligence reshapes global technological capabilities, the Nuclear Threat Initiative (NTI) and the China Arms Control and Disarmament Association (CACDA) are jointly calling for action to strengthen biosecurity and oversight and engage in responsible practices to prevent accidents or misuse.
New NTI Framework Tackles Misuse Risks in AIxBio Tools
New NTI | bio paper calls on tool developers and other AIxBio stakeholders to implement a managed access approach—allowing only validated users to access those biological AI models that contribute to biosecurity risks—to help reduce the risk that such tools will be deliberately misused to cause harm.
HHS Cancellation of Funding for mRNA Vaccines is a Dangerous Mistake that Puts Millions of Lives at Risk
A statement by Jaime M. Yassif, PhD, vice president, NTI Global Biological Policy and Programs.
B-roll North Korean Nuclear Test
B-Roll IRAN Natanz Enrichment Complex
B-roll Rattehalli Materials Plant - India
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
